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ABSTRACT
Multimorbidity is defined as patients living with two 
or more chronic health conditions. The prevalence 
of multimorbidity is increasing, driven by the ageing 
population, and represents a major challenge to all 
healthcare systems because these patients are heavy 
users of services. The link with oral health is growing 
although there is need for further robust evidence. There is 
also need for new models of care to address oral health in 
patients with multimorbidity.
INTRODUCTION
Multimorbidity is generating increasing 
interest; it has not been uniformly defined in 
the past and we have adopted the Academy 
of Medical Sciences definition ‘…the coexis-
tence of two or more chronic conditions in 
the same individual.’1 As worldwide mortality 
rates decrease combined with an ageing 
population, the number of people affected 
by multimorbidity has increased dramati-
cally.2 The prevalence of morbidity increases 
with age with and deprivation with people in 
deprived areas having the same prevalence of 
multimorbidity as more affluent patients who 
were 10–15 years older.1 3
Expenditure on healthcare rises almost 
exponentially with the number of chronic 
disorders that an individual has, so increasing 
multimorbidity generates financial pressures. 
This economic burden heightens the need to 
manage people with several chronic illnesses 
in more efficient ways.4 5
In a systematic analysis of global burden,6 
oral conditions were deemed endemic, 
affecting 3.9 billion people worldwide. 
Despite being largely preventable, dental 
caries was found to have the highest prev-
alence (35% globally) of the 291 included 
conditions; severe periodontitis, and severe 
tooth loss were sixth, and thirty- sixth, respec-
tively, while oral cancer is the eleventh most 
common malignancy worldwide.7
Perhaps unsurprisingly, WHO considers 
oral conditions a major public health 
problem;8 inextricably linked to overall 
health, poor oral health can lead to infec-
tion and pain and can have a subtle effect 
on well- being such as sleep, work and social 
confidence.9 While oral health conditions are not 
primarily viewed as life- threatening conditions,10 
those with poor oral health have a significant 
association with higher mortality.11
While oral conditions often have shared 
risk factors with other chronic conditions, 
it has been hypothesised that oral diseases, 
such as periodontitis, may contribute to a 
proinflammatory state.12 This may play a part 
in accelerating or exacerbating conditions 
related to chronic conditions, such as cardio-
vascular disease, which in 2016 accounted for 
17.9 million deaths globally.13 14
ASSOCIATION BETWEEN ORAL HEALTH AND 
GENERAL HEALTH
For the past three decades there has been 
and increasing focus on the relationship 
between oral disease and other commonly 
found medical diseases. The majority of the 
literature has focused on periodontitis15 and 
its relationship with other systemic inflammatory 
diseases, although no cause- effect relationships 
have been widely accepted.16
Disentangling a cause- effect relationship 
from shared risk factors has been problem-
atic due to study design challenges, though 
indirect evidence suggests an independent 
relationship between periodontal disease and 
conditions such as type 2 diabetes, rheuma-
toid arthritis, cardiovascular disease, Parkin-
son’s disease, psoriasis, respiratory infections 
and Alzheimer’s disease, among others.16
There continues to be emerging evidence 
that oral health plays a role in general 
chronic diseases. In particular, periodontal 
disease and diabetes mellitus have been 
described as having a ‘bi- directional’ rela-
tionship, meaning glycaemic control affects 
a person’s periodontal status, and vice versa. 
Studies have shown that people with diabetes 
who have severe gum disease—characterised 
as bleeding gums, gingival recession, tooth 
mobility and alveolar bone loss—also have 
higher HbA1c levels compared with those 
with healthier gums.17 One study indicated 
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that non- surgical periodontal treatment significantly 
improved metabolic control in patients with type 2 
diabetes.18 Conversely, raised levels of advanced glycation 
end products in patients with poorly controlled diabetes 
may result in production of proinflammatory cytokines. 
These cytokines in turn can induce periodontal tissue 
destruction.19
Indeed, periodontal disease has been shown to have 
associations with many other diseases. These include 
increased risk of heart attack or stroke, independent of 
the other well- known cardiovascular risk factors. Indirect 
mechanisms such as systemic inflammation have been 
proposed, with increased levels of inflammatory protein 
as found in patients with periodontitis, also being predic-
tors of future cardiac events.20 It has also been suggested 
that direct mechanisms such as bacteraemia and vascular 
infection from periodontal pathogens may contribute to 
aortic vasculopathy.21 A direct cause- effect relationship 
was suggested in a PAROKRANK Study22 and a signifi-
cant risk of first- time myocardial infarction was found 
in patients with periodontitis, this risk remaining signif-
icant even after adjustments were made for risk factors 
such as smoking and diabetes. The expectation that peri-
odontal treatment would therefore reduce the risk of 
cardiovascular events has not materialised however, with 
little evidence found in a recent umbrella review that 
non- surgical therapy reduces the risk of cardiovascular 
events.23
Furthermore, in some at- risk populations, poor oral 
health and periodontitis may be associated with certain 
respiratory conditions including pneumonia and chronic 
obstructive pulmonary disease (COPD). Typical respira-
tory pathogens have been shown to colonise the dental 
plaque of hospitalised intensive care and nursing home 
patients24 and it has been suggested that these pathogens 
may then become aspirated into the lungs and cause 
infection. One study reported that alveolar bone loss 
was an independent risk factor for COPD, supporting a 
possible role of periodontal disease in the pathogenesis 
of COPD or its progression.25
Further, maternal periodontal disease and low birth 
weight of infants has been shown to have an association.9 
Once again, it has been postulated that bacterial migra-
tion from periodontal tissues into blood circulation may 
stimulate the production of inflammatory mediators.
RISK FACTORS
One of the greatest risk factors is age- related deteri-
oration of the oral tissues and a higher probability of 
systemic illness.26 As populations age, maintaining oral 
care becomes problematic and gingival recession and 
root caries becomes more prevalent.27 It has been esti-
mated that in India almost half of those aged 75 years 
have an experience of root caries,28 which is a major cause 
of tooth loss.27 In the USA tooth loss increases with age and 
almost 19% of seniors (over 65 years) are edentulous.29 
Tooth loss has a significant effect on well- being, and has been 
related to a decline in nutrition and health, as food preferences 
move away from fresh vegetables and fruits towards softer foods.29 
Further, edentulous patients who retain their dental pros-
thesis overnight have increased risk of pneumonia.30
The decline in oral health in an ageing population has 
been linked to the side effects of polypharmacy related to 
chronic conditions. A plethora of commonly prescribed 
medications can induce hyposalivation, which increases 
the risk of oral disease including caries, periodontal 
disease and candidiasis.31
Certain chronic conditions which are more prevalent in 
the elderly can lead to a reduction in cognitive or motor 
skills. Patients with dementia can be reluctant to remove 
their dentures at night, which can lead to denture stoma-
titis. Additionally other progressive neurological disor-
ders such as Parkinson’s disease can affect motor function 
and has been associated with a greater risk of caries and 
periodontal disease.26
Risk factors are not confined to an ageing population 
and the burden is greatest on those from low socioeco-
nomic backgrounds, not least because WHO says treat-
ment of oral disease is costly, the fourth most expensive 
disease to treat in many countries.8
Stress, hygiene and trauma as well as the more common 
risk factors like unhealthy diet, smoking and alcohol 
consumption have been implicated32; therefore oral 
health improvement is not just in its treatment, but also 
prevention. However, in developing countries where oral 
health expenditure is already low, resources are largely 
focused on treatment of acute symptoms and emergency 
care. It is estimated that if treatment and preventative 
measures were widely available, the cost of dental caries 
for children alone would exceed total child healthcare 
expenditure.33 As a consequence, in many countries there 
are a number of difficulties in overcoming untreated 
dental disease.
In terms of risk factors, many are shared between oral 
and general chronic problems like diabetes and cardio-
vascular disease. These common modifiable factors 
usually relate to lifestyle habits. It is a well- established fact 
that smoking cigarettes increases the risk of lung cancer, 
but it also increases the risk of tooth loss as a result of 
periodontal disease.34 Therefore, there is an association 
between oral diseases and non- communicable diseases 
and by addressing these factors, the positive impact on 
the population would be significant.
CONCLUSION
It appears that many populations globally are experi-
encing multimorbidity and the available evidence about 
the burden, determinants, prevention and treatment 
of patients with multimorbidity is inadequate. Research 
gaps need to be filled across a wide range of perspec-
tives from biological mechanisms to healthcare systems 
management.1
In the meantime, implementation of public health 
measures in order to reduce exposure to risk factors is 
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key in reducing the burden of oral disease, and at the 
same time general diseases. It is likely that health inequal-
ities must be addressed in order for factors like sugar 
consumption, alcohol and smoking use to decrease.31 In 
terms of dental conditions, the disease process is largely 
avoidable, and as such prevention should be at the fore-
front of tackling this issue. This needs coordination and 
delivery by all health professionals as well as statutory and 
third sector organisations.
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